It was announced last week former UFC heavyweight champion Brock Lesnar failed an out-of-competition drug test from a June 28 sample taken by USADA.
The UFC has announced today that Lesnar also failed an in-competition drug test at UFC 200.
Lesnar failed both tests for the same banned substance, the UFC release stated. USADA has yet to reveal the name of the drug and won’t unless Lesnar makes it public first himself.
Find the UFC statement below:
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Brock Lesnar that his in-competition sample collection from July 9, 2016, at UFC 200, has tested positive for the same substance as his previously announced out-of-competition collection on June 28, 2016.
“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed at UFC 200 in Las Vegas.
“Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward.”
Last week, USADA confirmed that Lesnar had passed multiple drug tests before failing the one from a June 28 sample. Lesnar was tested eight times in total in the month leading up to UFC 200.
Lesnar is now facing a two-year ban from MMA. At UFC 200, Lesnar defeated Mark Hunt by unanimous decision.
Photo by Jeff Bottari/Zuffa LLC